Research of Pathological Imaging Diagnosis of Ocular Tumors Based on New Artificial Intelligence Algorithm

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-12-31

Study Completion Date

2022-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to establish a standardized process for obtaining digital pathological image information of ocular tumors; use modern pathological techniques to obtain the co-expression information of multiple biomarkers in the pathological tissues of ocular tumors, and finally construct standardized digital ocular tumors with biomarkers Pathology image database.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

OSPM-Enhanced AI Model to Identify Premalignant and Malignant Ocular Surface Tumors

NCT06567028

Performance of the Model

COMPLETED

Risk Stratification of Orbital Tumors Based on MRl and Artificial Intelligence

NCT06336499

Orbital Neoplasms

COMPLETED

Deep Learning in Retinoblastoma Detection and Monitoring.

NCT05308043

Retinoblastoma

UNKNOWN

Artificial Intelligence Neuropathologist

NCT05300113

CNS Tumor Neuropathology

UNKNOWN

AI-assisted Diagnosis of Malignant Brain Tumors

NCT07198256

Gliomas Brain Metastases, Adult Lymphoma +1 more

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is a prospective study. Patients with common and representative ocular tumors in the Department of Ophthalmology, Peking University Third Hospital, will be selected and enrolled after informed consent to collect basic clinical information, preoperative blood samples, and ocular tumors Obtain pathological image annotation data and genomics-related data from ocular tumor tissue specimens, use blood samples for genomics information analysis, provide multi-dimensional data for the development of artificial intelligence algorithms, and establish artificial intelligence-assisted image data for eye tumors Standardize the process and establish a multi-modal ocular tumor standardized database of "clinical information-tissue samples-pathological images-genomics data". The database and the diagnosis system are correlated with each other to provide optimal image data for later machine learning and related algorithm establishment, and finally the investigators will be completed the design of a new artificial intelligence-assisted diagnosis system for eye tumors.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Melanoma (Skin) Melanoma in Situ Nevus Eye Sebaceous Gland Carcinoma of the Eyelid Basal Cell Carcinoma Squamous Cell Carcinoma in Situ Ocular Tumor

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Melanoma and Nevus

Patients diagnosed with melanoma or/and nevus on the skin around the eye before surgery.

No interventions assigned to this group

Basal cell carcinoma;Squamous cell carcinoma;Sebaceous gland carcinoma

Patients diagnosed with basal cell carcinoma, squamous cell carcinoma, sebaceous gland carcinoma before surgery.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patients diagnosed with eye tumors and undergoing eye tumor surgery.
2. Patients sign informed consent for sample collection and sample transfer agreement, and can cooperate with long-term regular follow-up requirements.

Exclusion Criteria

1. Patients who are unable to undergo tumor surgery or retain samples due to various reasons .
2. Patients who are positive for hepatitis B, HIV, and syphilis.
3. Patient compliance is poor.

Eligible Sex

ALL

Accepts Healthy Volunteers

No